ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,025.00
-55.00 (-2.64%)
At close: Aug 24, 2026

ENBIO Revenue

ENBIO had revenue of 10.44B KRW in the quarter ending June 30, 2026, with 22.51% growth. This brings the company's revenue in the last twelve months to 36.18B, up 7.81% year-over-year. In the year 2025, ENBIO had annual revenue of 33.95B, down -4.77%.

Revenue (ttm)
36.18B
Revenue Growth
+7.81%
P/S Ratio
0.61
Revenue / Employee
452.28M
Employees
80
Market Cap
22.01B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202533.95B-1.70B-4.77%
Dec 31, 202435.65B1.63B4.79%
Dec 31, 202334.02B-215.53M-0.63%
Dec 31, 202234.24B773.80M2.31%
Dec 31, 202133.47B-1.10B-3.17%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Humax388.31B
EXA E&C205.20B
Dasan Solueta164.79B
OA Co., Ltd.104.86B
Studio Samick90.48B
Deep Commerce72.78B
C&R Research62.70B
T Scientific35.49B
Revenue Rankings